A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 - Miki, Y.; Swensen, J.; Shattuck-Eidens, D.; Futreal, P. A.; Harshman, K.; Tavtigian, S.; Liu, Q.; Cochran, C.; Bennett, L. M.; Ding, W. (Science, 1994)

Identification of the breast cancer susceptibility gene BRCA2 - Wooster, R.; Bignell, G.; Lancaster, J.; Swift, S.; Seal, S.; Mangion, J.; Collins, N.; Gregory, S.; Gumbs, C.; Micklem, G. (Nature, 1995)

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer - Foulkes, W. D.; Wong, N.; Brunet, J. S.; Begin, L. R.; Zhang, J. C.; Martinez, J. J.; Rozen, F.; Tonin, P. N.; Narod, S. A.; Karp, S. E. (Clin Cancer Res, 1997)

Familial invasive breast cancers: worse outcome related to BRCA1 mutations - Stoppa-Lyonnet, D.; Ansquer, Y.; Dreyfus, H.; Gautier, C.; Gauthier-Villars, M.; Bourstyn, E.; Clough, K. B.; Magdelenat, H.; Pouillart, P.; Vincent-Salomon, A. (J Clin Oncol, 2000)

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome - Foulkes, W. D.; Chappuis, P. O.; Wong, N.; Brunet, J. S.; Vesprini, D.; Rozen, F.; Yuan, Z. Q.; Pollak, M. N.; Kuperstein, G.; Narod, S. A. (Ann Oncol, 2000)

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data - Goffin, J. R.; Chappuis, P. O.; Begin, L. R.; Wong, N.; Brunet, J. S.; Hamel, N.; Paradis, A. J.; Boyd, J.; Foulkes, W. D. (Cancer, 2003)

Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients - Hampl, J. A.; Hampl, M.; Reiss, G.; Koch, R.; Saeger, H. D.; Schackert, H. K. (Anticancer Res, 2004)

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations - Rennert, G.; Bisland-Naggan, S.; Barnett-Griness, O.; Bar-Joseph, N.; Zhang, S.; Rennert, H. S.; Narod, S. A. (N Engl J Med, 2007)

Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations - Cortesi, L.; Turchetti, D.; Bertoni, C.; Bellei, R.; Mangone, L.; Vinceti, M.; Federico, M.; Silingardi, V.; Ferrari, S. (Genes Chromosomes Cancer, 2000)

BRCA1 dysfunction in sporadic basal-like breast cancer - Turner, N. C.; Reis-Filho, J. S.; Russell, A. M.; Springall, R. J.; Ryder, K.; Steele, D.; Savage, K.; Gillett, C. E.; Schmitt, F. C.; Ashworth, A. (Oncogene, 2007)

Basal-like breast cancer and the BRCA1 phenotype - Turner, N. C.; Reis-Filho, J. S. (Oncogene, 2006)

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment - Robson, M. E.; Chappuis, P. O.; Satagopan, J.; Wong, N.; Boyd, J.; Goffin, J. R.; Hudis, C.; Roberge, D.; Norton, L.; Begin, L. R. (Breast Cancer Res, 2004)

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review - Bonadona, V.; Dussart-Moser, S.; Voirin, N.; Sinilnikova, O. M.; Mignotte, H.; Mathevet, P.; Bremond, A.; Treilleux, I.; Martin, A.; Romestaing, P. (Breast Cancer Res Treat, 2007)

Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience - Cortesi, L.; Turchetti, D.; Marchi, I.; Fracca, A.; Canossi, B.; Battista, R.; Ruscelli, S.; Pecchi, A. R.; Torricelli, P.; Federico, M. (BMC Cancer, 2006)

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells - Tassone, P.; Tagliaferri, P.; Perricelli, A.; Blotta, S.; Quaresima, B.; Martelli, M. L.; Goel, A.; Barbieri, V.; Costanzo, F.; Boland, C. R.; Venuta, S. (Br J Cancer, 2003)

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin - Bhattacharyya, A.; Ear, U. S.; Koller, B. H.; Weichselbaum, R. R.; Bishop, D. K. (J Biol Chem, 2000)

The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells - Fedier, A.; Steiner, R. A.; Schwarz, V. A.; Lenherr, L.; Haller, U.; Fink, D. (Int J Oncol, 2003)

The relationship between the roles of BRCA genes in DNA repair and cancer predisposition - Tutt, A.; Ashworth, A. (Trends Mol Med, 2002)

The role of BRCA1 in the cellular response to chemotherapy - Kennedy, R. D.; Quinn, J. E.; Mullan, P. B.; Johnston, P. G.; Harkin, D. P. (J Natl Cancer Inst, 2004)

Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining - Audebert, M.; Salles, B.; Calsou, P. (J Biol Chem, 2004)

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy - Farmer, H.; McCabe, N.; Lord, C. J.; Tutt, A. N.; Johnson, D. A.; Richardson, T. B.; Santarosa, M.; Dillon, K. J.; Hickson, I.; Knights, C. (Nature, 2005)

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer - Chappuis, P. O.; Goffin, J.; Wong, N.; Perret, C.; Ghadirian, P.; Tonin, P. N.; Foulkes, W. D. (J Med Genet, 2002)

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/10/90/prepub